Anti-CD20 Therapy and Disability Progression in Relapsing Multiple Sclerosis. Current Research in Neurology and Neurosurgery, [S. l.], v. 7, n. 1, p. 17–24, 2024. DOI: 10.5281/zenodo.22310428. Disponível em: https://somatopub.com/index.php/CRNN/article/view/409. Acesso em: 31 oct. 2026.